THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE IN TYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS

被引:84
作者
KNOBL, P
SCHERNTHANER, G
SCHNACK, C
PIETSCHMANN, P
GRIESMACHER, A
PRAGER, R
MULLER, M
机构
[1] RUDOLFSTIFTUNG HOSP,DEPT MED 1,JUCHGASSE 25,A-1030 VIENNA,AUSTRIA
[2] UNIV VIENNA,DEPT MED 2,A-1010 VIENNA,AUSTRIA
[3] UNIV VIENNA,DEPT SURG 2,A-1010 VIENNA,AUSTRIA
关键词
DIABETES-MELLITUS; COAGULATION FACTORS; LIPID PEROXIDES; ENDOTHELIAL CELL; CARDIOVASCULAR RISK; DIABETIC NEPHROPATHY; URINARY ALBUMIN EXCRETION;
D O I
10.1007/BF02374497
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parameters of haemostasis, endothelial cell markers and lipid peroxide levels were studied in 64 Type 1 (insulin-dependent) and 94 Type 2 (non-insulin-dependent) diabetic patients according to their urinary albumin excretion rate in comparison with age-matched control subjects. We determined plasma levels of fibrinogen (Clauss' method), coagulation factor VII:activity (clotting assay), factor VII antigen, protein C and S antigen, von Willebrand factor antigen, D-dimer concentration (ELISA), and lipid-peroxide levels (thiobarbituric acid) in relation to urinary albumin excretion rate (RIA). Significant positive correlations were found between urinary albumin excretion rate and plasma fibrinogen (p < 0.005, p < 0.02), factor VII activity (p < 0.0002, p < 0.002), factor VII antigen (p < 0.0001, p < 0.001), protein C (p < 0.003, p < 0.05), and lipid peroxides (p < 0.02, p < 0.004) in Type 1 as well as in Type 2 diabetes. Von Willebrand factor (p < 0.001) and protein S (p < 0.0005) correlated with albuminuria only in patients with Type 1 diabetes. Although most of the haemostatic abnormalities are already found in normoalbuminuric patients, the significant positive correlations to urinary albumin excretion indicate that endothelial cell damage and coagulation disorders deteriorate with the progression of diabetic nephropathy.
引用
收藏
页码:1045 / 1050
页数:6
相关论文
共 34 条
[1]   POSSIBLE ROLE FOR INCREASED C4B-BINDING PROTEIN LEVEL IN ACQUIRED PROTEIN-S DEFICIENCY IN TYPE-I DIABETES [J].
CERIELLO, A ;
BARBANTI, M ;
GIUGLIANO, D ;
LEFEBVRE, P ;
QUATRARO, A ;
MARCHI, E .
DIABETES, 1990, 39 (04) :447-449
[2]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[3]   FREE-RADICAL ACTIVITY AND HEMOSTATIC FACTORS IN NIDDM PATIENTS WITH AND WITHOUT MICROALBUMINURIA [J].
COLLIER, A ;
RUMLEY, A ;
RUMLEY, AG ;
PATERSON, JR ;
LEACH, JP ;
LOWE, GDO ;
SMALL, M .
DIABETES, 1992, 41 (08) :909-913
[4]   HEMOSTATIC VARIABLES ASSOCIATED WITH DIABETES AND ITS COMPLICATIONS [J].
FULLER, JH ;
KEEN, H ;
JARRETT, RJ ;
OMER, T ;
MEADE, TW ;
CHAKRABARTI, R ;
NORTH, WRS ;
STIRLING, Y .
BMJ-BRITISH MEDICAL JOURNAL, 1979, 2 (6196) :964-966
[5]   EFFECT OF VITAMIN-E SUPPLEMENTATION ON PLATELET THROMBOXANE-A2 PRODUCTION IN TYPE-I DIABETIC-PATIENTS - DOUBLE-BLIND CROSSOVER TRIAL [J].
GISINGER, C ;
JEREMY, J ;
SPEISER, P ;
MIKHAILIDIS, D ;
DANDONA, P ;
SCHERNTHANER, G .
DIABETES, 1988, 37 (09) :1260-1264
[6]  
Jarrett R J, 1984, Diabet Med, V1, P17
[7]   CORONARY HEART-DISEASE IN YOUNG TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH AND WITHOUT DIABETIC NEPHROPATHY - INCIDENCE AND RISK-FACTORS [J].
JENSEN, T ;
BORCHJOHNSEN, K ;
KOFOEDENEVOLDSEN, A ;
DECKERT, T .
DIABETOLOGIA, 1987, 30 (03) :144-148
[8]  
JENSEN T, 1989, LANCET, V1, P461
[9]  
JUMMING L, 1988, LAB INVEST, V61, P588
[10]   DIABETES, FIBRINOGEN, AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM EXPERIENCE [J].
KANNEL, WB ;
DAGOSTINO, RB ;
WILSON, PWF ;
BELANGER, AJ ;
GAGNON, DR .
AMERICAN HEART JOURNAL, 1990, 120 (03) :672-676